Regular kidney function tests help ensure safe long-term use
Semaglutide is a GLP-1 receptor agonist prescribed, when clinically appropriate, as part of a medical weight-loss plan
Within the small intestine, pancreatic enzymes, including trypsin, chymotrypsin, elastase, and carboxy-/aminopeptidases, continue proteolysis, which reduces peptides to fragments or amino acids
New-onset proliferative diabetic retinopathy (PDR) (grade R3M0, R3M1) occurred in 1.1% of tirzepatide-exposed ( n =33) and 0.5% of tirzepatide-unexposed ( n =17) individuals
Knop FK, Aroda VR, do Vale RD, Holst-Hansen T, Laursen PN, Rosenstock J, et al
Conclusion GLP-1 medications offer a genuinely effective path to medical weight loss for patients who qualify, but how you do it matters